Hiddo Lambers Heerspink

2016

Creatinine, cystatin c, beta-2-microglobulin and beta-trace protein: Which marker is best to assess changes in egfr over time?

Schutte, E., Lutgers, H. L., Bakker, S. J. L., Wolffenbuttel, B. H. R., Gansevoort, R. T. & Heerspink, H. J. L., mei-2016, In: Nephrology, Dialysis, Transplantation. 31, blz. 162-162 1 blz., SP226.

Onderzoeksoutput › Academic

Dapagliflozin reduces albuminuria in patients with diabetes and hypertension receiving renin-angiotensin blockers

Heerspink, H. J. L., Johnsson, E., Gause-Nilsson, I., Cain, V. A. & Sjostrom, C. D., jun.-2016, In: Diabetes obesity & metabolism. 18, 6, blz. 590-597 8 blz.

Onderzoeksoutput › Academic › peer review

Open Access

Bestand

166 Citaten (Scopus)

423 Downloads (Pure)

Determining the Optimal Protocol for Measuring an Albuminuria Class Transition in Clinical Trials in Diabetic Kidney Disease

Kropelin, T. F., de Zeeuw, D., Remuzzi, G., Bilous, R., Parving, H.-H. & Heerspink, H. J. L., nov.-2016, In: Journal of the American Society of Nephrology. 27, 11, blz. 3405-3412 8 blz.

Onderzoeksoutput › Academic › peer review

9 Citaten (Scopus)

Early renin-angiotensin system intervention is more beneficial than late intervention in delaying end-stage renal disease in patients with type 2 diabetes

Schievink, B., Kropelin, T., Mulder, S., Parving, H.-H., Remuzzi, G., Dwyer, J., Vemer, P., de Zeeuw, D. & Heerspink, H. J. L., jan.-2016, In: Diabetes obesity & metabolism. 18, 1, blz. 64-71 8 blz.

Onderzoeksoutput › Academic › peer review

63 Citaten (Scopus)

Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes

Parving, H.-H., Lambers-Heerspink, H. & de Zeeuw, D., 3-nov.-2016, In: New England Journal of Medicine. 375, 18, blz. 1800-1801 2 blz.

Onderzoeksoutput: Letter › Academic › peer review

High urinary sulfate concentration is associated with reduced risk of renal disease progression in type 2 diabetes

van den Born, J. C., Frenay, A.-R. S., Bakker, S. J. L., Pasch, A., Hillebrands, J.-L., Heerspink, H. J. L. & Goor, van, H., 1-mei-2016, In: Nitric oxide-Biology and chemistry. 55-56, blz. 18-24 7 blz.

Onderzoeksoutput › Academic › peer review

28 Citaten (Scopus)

Individualized prediction of the effect of angiotensin receptor blockade on renal and cardiovascular outcomes in patients with diabetic nephropathy

van der Sande, N. G. C., Dorresteijn, J. A. N., Visseren, F. L. J., Dwyer, J. P., Blankestijn, P. J., van der Graaf, Y. & Heerspink, H. L. J., nov.-2016, In: Diabetes obesity & metabolism. 18, 11, blz. 1120-1127 8 blz.

Onderzoeksoutput › Academic › peer review

11 Citaten (Scopus)

Individual long-term albuminuria exposure during angiotensin receptor blocker therapy is the optimal predictor for renal outcome

Kröpelin, T. F., de Zeeuw, D., Holtkamp, F. A., Packham, D. K. & Heerspink, H. J. L., sep.-2016, In: Nephrology, Dialysis, Transplantation. 31, 9, blz. 1471-1477 7 blz.

Onderzoeksoutput › Academic › peer review

16 Citaten (Scopus)

Is a reduction in albuminuria associated with renal and cardiovascular protection? A post-hoc analysis of the ALTITUDE trial

Heerspink, H. J. L., Ninomiya, T., Persson, F., Brenner, B. M., Brunel, P., Chaturvedi, N., Desai, A. S., Haffner, S. M., McMurray, J. J. V., Solomon, S. D., Pfeffer, M. A., Parving, H.-H. & de Zeeuw, D., feb.-2016, In: Diabetes obesity & metabolism. 18, 2, blz. 169-177 9 blz.

Onderzoeksoutput › Academic › peer review

53 Citaten (Scopus)

Linagliptin Reduces Arterial Stiffness and Arterial Inflammation in Persons With Early Type 2 Diabetes: a Double-blind, Randomized Controlled Trial

de Boer, S. A., Heerspink, H. J., Lefrandt, J. D., van Roon, A. M., Orozco, L. E. J., Glaudemans, A. W., Kamphuisen, P. W., Slart, R. H. & Mulder, D. J., 11-nov.-2016, In: Circulation. 134, 4 blz., 12647.

Onderzoeksoutput › Academic

Methods of treating CKD using predictors of fluid retention

Kohan, D. E. (Uitvinder), Heerspink, H. (Uitvinder), de Zeeuw, D. (Uitvinder), Coll, B. (Uitvinder) & Andress, D. (Uitvinder), 12-mei-2016, Octrooi Nr. WO2016073846, Prioriteitsdatum 7-nov.-2014

Onderzoeksoutput: Patent

Open Access

Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure: A Meta-analysis

Tangri, N., Grams, M. E., Levey, A. S., Coresh, J., Appel, L. J., Astor, B. C., Chodick, G., Collins, A. J., Djurdjev, O., Elley, R., Evans, M., Garg, A. X., Hallan, S. I., Nicer, L. A., Ito, S., Jee, S. H., Kovesdy, C. P., Kronenberg, F., Heerspink, H. J. L. & Marks, A. & 9 anderen, Nadkarni, G. N., Navaneethan, S. D., Nelson, R. G., Titze, S., Sarnak, M. J., Stengel, B., Woodward, M., Iseki, K. & CKD Prognosis Consortium, 12-jan.-2016, In: JAMA - Journal of the American Medical Association. 315, 2, blz. 164-174 11 blz.

Onderzoeksoutput › Academic › peer review

Open Access

Bestand

474 Citaten (Scopus)

738 Downloads (Pure)

Novel anti-inflammatory drugs for the treatment of diabetic kidney disease

Heerspink, H. J. L. & De Zeeuw, D., aug.-2016, In: Diabetologia. 59, 8, blz. 1621-1623 3 blz.

Onderzoeksoutput › Academic › peer review

Open Access

Bestand

19 Citaten (Scopus)

270 Downloads (Pure)

Plasma calcidiol, calcitriol, and parathyroid hormone and risk of new onset heart failure in a population-based cohort study

Meems, L. M. G., Brouwers, F. P., Joosten, M. M., Lambers Heerspink, H. J., de Zeeuw, D., Bakker, S. J. L., Gansevoort, R. T., van Gilst, W. H., van der Harst, P. & de Boer, R. A., sep.-2016, In: JACC. Heart failure. 3, 3, blz. 189-197 9 blz.

Onderzoeksoutput › Academic › peer review

Open Access

Bestand

18 Citaten (Scopus)

290 Downloads (Pure)

Prediction of the effect of atrasentan on renal and heart failure outcomes based on short-term changes in multiple risk markers

Schievink, B., de Zeeuw, D., Smink, P. A., Andress, D., Brennan, J. J., Coll, B., Correa-Rotter, R., Hou, F. F., Kohan, D., Kitzman, D. W., Makino, H., Parving, H.-H., Perkovic, V., Remuzzi, G., Tobe, S., Toto, R., Hoekman, J. & Heerspink, H. J. L., mei-2016, In: European Journal of Preventive Cardiology. 23, 7, blz. 758-768 11 blz.

Onderzoeksoutput › Academic › peer review

29 Citaten (Scopus)

Predictors of HbA1c levels in patients initiating metformin

Martono, D. P., Hak, E., Lambers Heerspink, H., Wilffert, B. & Denig, P., dec.-2016, In: Current Medical Research and Opinion. 32, 12, blz. 2021-2028 8 blz.

Onderzoeksoutput › Academic › peer review

Open Access

Bestand

11 Citaten (Scopus)

100 Downloads (Pure)

Prevalence and distribution of (micro)albuminuria in toddlers

Gracchi, V., van den Belt, S. M., Küpers, L. K., Corpeleijn, E., de Zeeuw, D. & Heerspink, H. J. L., 1-okt.-2016, In: Nephrology, Dialysis, Transplantation. 31, 10, blz. 1686-1692 7 blz.

Onderzoeksoutput › Academic › peer review

Open Access

Bestand

17 Citaten (Scopus)

297 Downloads (Pure)

Proteomics for prediction of disease progression and response to therapy in diabetic kidney disease

Pena, M. J., Mischak, H. & Heerspink, H. J. L., sep.-2016, In: Diabetologia. 59, 9, blz. 1819-1831 13 blz.

Onderzoeksoutput › peer review

35 Citaten (Scopus)

Renal outcomes with aliskiren in patients with type 2 diabetes: a prespecified secondary analysis of the ALTITUDE randomised controlled trial

Heerspink, H. J. L., Person, F., Brenner, B. M., Chaturvedi, N., Brunel, P., McMurray, J. J., Desai, A. S., Solomon, S. D., Pfeffer, M. A., Parving, H.-H. & de Zeeuw, D., apr.-2016, In: Lancet Diabetes & Endocrinology. 4, 4, blz. 309-317 9 blz.

Onderzoeksoutput › Academic › peer review

43 Citaten (Scopus)

Serum metabolites predict response to angiotensin II receptor blockers in patients with diabetes mellitus

Pena, M. J., Heinzel, A., Rossing, P., Parving, H.-H., Dallmann, G., Rossing, K., Andersen, S., Mayer, B. & Heerspink, H. J. L., 5-jul.-2016, In: Journal of translational medicine. 14, 1, blz. 203 11 blz., 203.

Onderzoeksoutput › Academic › peer review

Open Access

Bestand

17 Citaten (Scopus)

223 Downloads (Pure)

Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus: Cardiovascular and Kidney Effects, Potential Mechanisms, and Clinical Applications

Heerspink, H. J. L., Perkins, B. A., Fitchett, D. H., Husain, M. & Cherney, D. Z. I., 6-sep.-2016, In: Circulation. 134, 10, blz. 752-772 21 blz.

Onderzoeksoutput › Academic › peer review

978 Citaten (Scopus)

The association of albuminuria and high-sensitivity C-reactive protein with the efficacy of HMG-coenzyme A reductase inhibitors for cardiovascular event prevention

Ozyilmaz, A., Boersma, C., Visser, S. T., Postma, M. J., de Jong-van den Berg, L. T. W., Lambers-Heerspink, H. J., de Jong, P. E. & Gansevoort, R. T., mei-2016, In: European Journal of Preventive Cardiology. 23, 8, blz. 847-855 9 blz.

Onderzoeksoutput › Academic › peer review

Unmet need in diabetic nephropathy: failed drugs or trials?

de Zeeuw, D. & Heerspink, H. J. L., aug.-2016, In: Lancet Diabetes & Endocrinology. 4, 8, blz. 638-640 3 blz.

Onderzoeksoutput › Academic › peer review

45 Citaten (Scopus)

Urine Albumin-Creatinine Ratio Versus Albumin Excretion for Albuminuria Staging: A Prospective Longitudinal Cohort Study

Vart, P., Scheven, L., Lambers Heerspink, H. J., de Jong, P. E., de Zeeuw, D., Gansevoort, R. T. & PREVEND Study Group and the RENAAL Investigators, jan.-2016, In: American Journal of Kidney Diseases. 67, 1, blz. 70-78 9 blz.

Onderzoeksoutput › Academic › peer review

27 Citaten (Scopus)

Utility of the CKD273 peptide classifier in predicting chronic kidney disease progression

Critselis, E. & Heerspink, H. L., feb.-2016, In: Nephrology, Dialysis, Transplantation. 31, 2, blz. 249-254 6 blz.

Onderzoeksoutput › Academic › peer review

44 Citaten (Scopus)

Vitamin D receptor activator and dietary sodium restriction to reduce residual urinary albumin excretion in chronic kidney disease (ViRTUE study): rationale and study protocol

Keyzer, C. A., de Jong, M. A., van Breda, G. F., Vervloet, M. G., Laverman, G. D., Hemmelder, M., Janssen, W. M., Heerspink, H. J. L., Navis, G., de Borst, M. H. & Holland Nephrology Study HONEST, jul.-2016, In: Nephrology, Dialysis, Transplantation. 31, 7, blz. 1081-1087 7 blz.

Onderzoeksoutput › peer review

8 Citaten (Scopus)

2015

18F-FDG-PET-CT assessed subclinical arterial inflammation is positively associated with non-invasive markers of arterial stiffness in recently diagnosed type 2 diabetes patients

de Boer, S. A., Hovinga-de Boer, M. C., Lefrandt, J. D., Heerspink, H. J. L., Glaudemans, A. W. J. M., Mulder, D. J. & Slart, R. H. J. A., okt.-2015, In: European Journal of Nuclear Medicine and Molecular Imaging. 42, blz. S194-S194 1 blz.

Onderzoeksoutput › Academic

Albuminuria Is an Appropriate Therapeutic Target in Patients with CKD: The Pro View

Lambers Heerspink, H. & Gansevoort, R. T., jun.-2015, In: Clinical Journal of the American Society of Nephrology. 10, 6, blz. 1079-1088 10 blz.

Onderzoeksoutput › Academic › peer review

129 Citaten (Scopus)

A Meta-analysis of the Association of Estimated GFR, Albuminuria, Age, Race, and Sex With Acute Kidney Injury

Grams, M. E., Sang, Y., Ballew, S. H., Gansevoort, R. T., Kimm, H., Kovesdy, C. P., Naimark, D., Oien, C., Smith, D. H., Coresh, J., Sarnak, M. J., Stengel, B., Tonelli, M. & CKD Prognosis Consortium, okt.-2015, In: American Journal of Kidney Diseases. 66, 4, blz. 591-601 11 blz.

Onderzoeksoutput › Academic › peer review

148 Citaten (Scopus)

A Meta-analysis of the Association of Estimated GFR, Albuminuria, Diabetes Mellitus, and Hypertension With Acute Kidney Injury

James, M. T., Grams, M. E., Woodward, M., Elley, C. R., Green, J. A., Wheeler, D. C., de Jong, P., Gansevoort, R. T., Levey, A. S., Warnock, D. G., Sarnak, M. J. & CKD Prognosis Consortium, okt.-2015, In: American Journal of Kidney Diseases. 66, 4, blz. 602-612 11 blz.

Onderzoeksoutput › Academic › peer review

226 Citaten (Scopus)

A Panel of Novel Biomarkers Representing Different Disease Pathways Improves Prediction of Renal Function Decline in Type 2 Diabetes

Pena, M. J., Heinzel, A., Heinze, G., Alkhalaf, A., Bakker, S. J. L., Nguyen, T. Q., Goldschmeding, R., Bilo, H. J. G., Perco, P., Mayer, B., de Zeeuw, D. & Lambers Heerspink, H., 14-mei-2015, In: PLoS ONE. 10, 5, 16 blz., e0120995.

Onderzoeksoutput › Academic › peer review

Open Access

Bestand

56 Citaten (Scopus)

496 Downloads (Pure)

Assessing the Validity of Surrogate Outcomes for ESRD: A Meta-Analysis

Jun, M., Turin, T. C., Woodward, M., Perkovic, V., Heerspink, H. J. L., Manns, B. J., Tonelli, M. & Hemmelgarn, B. R., sep.-2015, In: Journal of the American Society of Nephrology. 26, 9, blz. 2289-2302 14 blz.

Onderzoeksoutput › Academic › peer review

38 Citaten (Scopus)

A study on the association between vitamin d and pth levels with new onset heart failure in the general population

Meems, L. M. G., Brouwers, F. P., Joosten, M. M., Heerspink, H. L., De Zeeuw, D., Bakker, S. J. L., Gansevoort, R. T., Van Gilst, W. H., Van der Harst, P. & De Boer, R. A., mei-2015, In: European Journal of Heart Failure. 17, blz. 263-263 1 blz.

Onderzoeksoutput › Academic

Diseases of Renal Microcirculation: Diabetic Nephropathy

Riphagen, I. J., Lambers Heerspink, H. J., Gans, R. O. B. & Gaillard, C. A., 2015, Diseases of Renal Microcirculation: Diabetic Nephropathy. Lanzer, P. (uitgave). Springer Berlin Heidelberg, blz. 1-34 34 blz.

Onderzoeksoutput › Academic › peer review

Diseases of Renal Microcirculation: Diabetic Nephropathy

Riphagen, I., Heerspink, H., Gans, R. O. B. & Gaillard, C. A., 2-feb.-2015, Pan Vascular Medicine. Springer, blz. 3739-3768 30 blz.

Onderzoeksoutput › Academic › peer review

2 Citaten (Scopus)

Drug-Induced Reduction in Albuminuria Is Associated with Subsequent Renoprotection: A Meta-Analysis

Lambers Heerspink, H. J., Kropelin, T. F., Hoekman, J., de Zeeuw, D. & Reducing Albuminuria Surrogate, aug.-2015, In: Journal of the American Society of Nephrology. 26, 8, blz. 2055-2064 10 blz.

Onderzoeksoutput › Academic › peer review

206 Citaten (Scopus)

Drugs meeting the molecular basis of diabetic kidney disease: bridging from molecular mechanism to personalized medicine

Heerspink, H. J. L., Oberbauer, R., Perco, P., Heinzel, A., Heinze, G., Mayer, G. & Mayer, B., aug.-2015, In: Nephrology, Dialysis, Transplantation. 30, blz. 105-112 8 blz.

Onderzoeksoutput › peer review

20 Citaten (Scopus)

Erratum to: Abstracts of the 51st Annual Meeting of the EASD, Stockholm 2015. 'Dapagliflozin reduces albuminuria on top of renin-angiotensin system blockade in hypertensive patients with diabetes' (vol 58, pg 1, 2015)

Heerspink, H. J. L., Johnsson, E., Gause-Nilsson, I. & Sjostrom, C., dec.-2015, In: Diabetologia. 58, 12, blz. 2901 1 blz.

Onderzoeksoutput

1 Citaat (Scopus)

Fibroblast Growth Factor 23 and the Antiproteinuric Response to Dietary Sodium Restriction During Renin-Angiotensin-Aldosterone System Blockade

Humalda, J. K., Lambers Heerspink, H. J., Kwakernaak, A. J., Slagman, M. C. J., Waanders, F., Vervloet, M. G., Ter Wee, P. M., Navis, G., de Borst, M. H. & NIGRAM Consortium, feb.-2015, In: American Journal of Kidney Diseases. 65, 2, blz. 259-266 8 blz.

Onderzoeksoutput › Academic › peer review

26 Citaten (Scopus)

New nonabsorbable potassium-exchange resins in hyperkalaemia

Roscioni, S. S. & Lambers Heerspink, H., apr.-2015, In: Nature Reviews Nephrology. 11, 4, blz. 205-206 2 blz.

Onderzoeksoutput › Academic › peer review

3 Citaten (Scopus)

Number and frequency of albuminuria measurements in clinical trials in diabetic nephropathy

Kröpelin, T. F., de Zeeuw, D., Andress, D. L., Bijlsma, M. J., Persson, F., Parving, H.-H. & Lambers Heerspink, H., 6-mrt.-2015, In: Clinical Journal of the American Society of Nephrology. 10, 3, blz. 410-416 7 blz.

Onderzoeksoutput › Academic › peer review

Open Access

Bestand

22 Citaten (Scopus)

35 Downloads (Pure)

Plasma 1,25-Dihydroxyvitamin D and the Risk of Developing Hypertension: The Prevention of Renal and Vascular End-Stage Disease Study

van Ballegooijen, A. J., Gansevoort, R. T., Lambers-Heerspink, H. J., de Zeeuw, D., Visser, M., Brouwer, I. A., Kema, I. P., de Borst, M. H., Bakker, S. J. L. & Joosten, M. M., sep.-2015, In: Hypertension. 66, 3, blz. 563-570 8 blz.

Onderzoeksoutput › Academic › peer review

29 Citaten (Scopus)

Plasma proteomics classifiers improve risk prediction for renal disease in patients with hypertension or type 2 diabetes

Pena, M. J., Jankowski, J., Heinze, G., Kohl, M., Heinzel, A., Bakker, S. J. L., Gansevoort, R. T., Rossing, P., de Zeeuw, D., Heerspink, H. J. L. & Jankowski, V., okt.-2015, In: Journal of Hypertension. 33, 10, blz. 2123-2132 10 blz.

Onderzoeksoutput › Academic › peer review

21 Citaten (Scopus)

Plasma Vitamin D Level and Change in Albuminuria eGFR According to Sodium Intake

Keyzer, C. A., Lambers-Heerspink, H. J., Joosten, M. M., Deetman, P. E., Gansevoort, R. T., Navis, G., Kema, I. P., de Zeeuw, D., Bakker, S. J. L., de Borst, M. H. & PREVEND Study Group, dec.-2015, In: Clinical Journal of the American Society of Nephrology. 10, 12, blz. 2119-2127 9 blz.

Onderzoeksoutput › Academic › peer review

30 Citaten (Scopus)

Pleiotropic effects of type 2 diabetes management strategies on renal risk factors

Muskiet, M. H. A., Tonneijck, L., Smits, M. M., Kramer, M. H. H., Lambers Heerspink, H. & van Raalte, D. H., mei-2015, In: Lancet Diabetes & Endocrinology. 3, 5, blz. 367-381 15 blz.

Onderzoeksoutput › peer review

71 Citaten (Scopus)

Predictors of Atrasentan-Associated Fluid Retention and Change in Albuminuria in Patients with Diabetic Nephropathy

Kohan, D. E., Lambers Heerspink, H. J., Coll, B., Andress, D., Brennan, J. J., Kitzman, D. W., Correa-Rotter, R., Makino, H., Perkovic, V., Hou, F. F., Remuzzi, G., Tobe, S. W., Toto, R., Parving, H.-H. & de Zeeuw, D., 4-sep.-2015, In: Clinical Journal of the American Society of Nephrology. 10, 9, blz. 1568-1574 7 blz.

Onderzoeksoutput › Academic › peer review

Open Access

Bestand

33 Citaten (Scopus)

47 Downloads (Pure)

Predictors of response in initial users of metformin and sulphonylurea derivatives: A systematic review

Martono, D. P., Lub, R., Heerspink, H. J. L., Hak, E., Wilffert, B. & Denig, P., jul.-2015, In: Diabetic Medicine. 32, 7, blz. 853-864 12 blz.

Onderzoeksoutput › peer review

Open Access

Bestand

27 Citaten (Scopus)

48 Downloads (Pure)

Prognostic clinical and molecular biomarkers of renal disease in type 2 diabetes

Pena, M. J., de Zeeuw, D., Mischak, H., Jankowski, J., Oberbauer, R., Woloszczuk, W., Benner, J., Dallmann, G., Mayer, B., Mayer, G., Rossing, P. & Lambers Heerspink, H. J., aug.-2015, In: Nephrology, Dialysis, Transplantation. 30, blz. 86-95 10 blz.

Onderzoeksoutput › peer review

35 Citaten (Scopus)

Rebuttal of the Con View: Albuminuria Is an Appropriate Therapeutic Target in Patients with CKD

Lambers Heerspink, H. & Gansevoort, R. T., jun.-2015, In: Clinical Journal of the American Society of Nephrology. 10, 6, blz. 1099-1099 1 blz.

Onderzoeksoutput › Academic › peer review

4 Citaten (Scopus)

Relevance of correction for drift and day-to-day variation in cystatin C measurement: a post-hoc analysis of the PREVEND cohort, with independent replication in the ESTHER cohort

Vart, P., Bakker, S. J. L., Schoettker, B., de Zeeuw, D., Rothenbacher, D., Brenner, H., Lambers Heerspink, H. J., Saum, K.-U., Reijneveld, S. A., Bultmann, U., Koenig, W. & Gansevoort, R., aug.-2015, In: Clinical chemistry and laboratory medicine. 53, 9, blz. 1381-1390 10 blz.

Onderzoeksoutput › Academic › peer review

9 Citaten (Scopus)

Hiddo Lambers Heerspink

Onderzoeksoutput

Zoekresultaten